Eyenovia, Inc. Profile Avatar - Palmy Investing

Eyenovia, Inc.

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutica…

Biotechnology
US, New York [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Eyenovia, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Eyenovia, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Eyenovia, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of EYEN's Analysis
CIK: 1682639 CUSIP: 30234E104 ISIN: US30234E1047 LEI: - UEI: -
Secondary Listings
EYEN has no secondary listings inside our databases.